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Abstract: Nuclear factor kappa B (NF-kB) is one of the most important transcription factors whose 
modulation triggers a cascade of signaling events, namely the expression of many cytokines, enzymes, chemokines, and 
adhesion molecules, some of which being potential key targets for intervention in the treatment of inflammatory condi-
tions. The 2-styrylchromones (2-SC) designation represents a well-recognized group of natural and synthetic chromones, 
vinylogues of flavones (2-phenylchromones). Several 2-SC were recently tested for their anti-inflammatory potential, re-
garding the arachidonic acid metabolic cascade, showing some motivating results. In addition, several flavones with struc-
tural similarities to 2-SC have shown NF-kB inhibitory properties. Hence, the aim of the present work was to continue the 
investigation on the interference of 2-SC in inflammatory pathways. Herein we report their effects on lipopolysaccharide 
(LPS)-induced NF-kB activation and consequent production of proinflammatory cytokines/chemokine, using a human 
monocytic cell line (THP-1). From the twelve 2-SC tested, three of them were able to significantly inhibit the NF-kB acti-
vation and to reduce the production of the proinflammatory cytokines/chemokine. The compound 3’,4’,5-trihydroxy-2-
styrylchromone stood up as the most active in both assays, being a promising candidate for an anti-inflammatory drug. 
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1. INTRODUCTION 
Nuclear factor kappa B (NF-kB) is one of the most im-
portant transcription factors whose modulation triggers a 
cascade of signaling events, some of which are potential key 
targets for intervention in the treatment of inflammatory 
conditions. In addition, NF-kB activation has been linked to 
the carcinogenesis process because of its role in differentia-
tion, inflammation and cell growth [1]. 
In resting cells, NF-kB, which is composed mainly of 
two proteins, p50 and p65, is present within the cytoplasm in 
an inactive state, bound to its inhibitory protein, IB. How-
ever, a number of proinflammatory stimuli [cytokines such 
as tumour necrosis factor (TNF)- or interleukin (IL)-1, oxi-
dative stress, infectious agents] can activate NF-kB in differ-
ent cell types. These inflammatory stimulations can initiate 
an intracellular signaling cascade leading to IB phos- 
phorylation, by IB kinase (IKK) complex, with its subse-
quent dissociation from NF-kB and degradation by the 
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proteasome. Once liberated from its inhibitory protein, NF-
kB translocates to the nucleus, where it orchestrates the tran-
scription of a number of proinflammatory genes by binding 
to B motifs found in the promoter or enhancer region. This 
activates the expression of many mediators of the inflamma-
tion including, cytokines, enzymes, chemokines, and adhe-
sion molecules [2]. 
Lipopolysaccharide (LPS) is a surface component of 
gram-negative bacteria released upon host infection. Its in-
teraction with Toll-like receptor 4 (TLR4), located in cell 
membrane, initiates a signal transduction pathway, which 
leads, among other events, to the activation of NF-kB [3]. In 
monocytes, LPS-dependent activation of NF-kB complexes 
induces a rapid but transient expression of a defined set of 
genes including TNF-, IL-1, IL-6 and IL-8 [4]. These 
proinflammatory mediators have shown to play important 
roles in the pathogenesis of chronic inflammatory and auto-
immune diseases such as rheumatoid arthritis, inflammatory 
bowel disease, or multiple sclerosis [5-8]. 
The 2-styrylchromones (2-SC) designation represents a 
well recognized group of natural and synthetic chromones, 
vinylogues of flavones (2-phenylchromones). As it occurs 
for flavones, several studies performed with 2-SC have dis-
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closed interesting activities with potential therapeutic appli-
cations, namely, neuroprotective action [9] and possible use 
in the treatment of cancers [5-8, 10-13], allergies [14], viral 
infections [15-17], gout [18] and oxidative stress related 
damage [19]. In fact the antioxidant properties of 2-SC have 
been shown in cellular [19] and non-cellular systems [20, 
21]. In a recent study, performed by our group, a number of 
2-SC were shown to have anti-inflammatory potential by 
inhibiting both the production of leukotriene B4 in human 
neutrophils and the activity of the enzyme cyclooxygenase 
(COX)-1 in a non-cellular system [22]. Those promising 
results lead us to continue the investigation on the interfer-
ence of 2-SC (Fig. 1) in inflammatory pathways. Herein we 
report their effects on LPS-induced NF-kB activation and 
production of TNF-, IL-1, IL-6 and IL-8 due to the above 
mentioned relevance of the NF-kB pathway in the inflamma-
tory process and also to the fact that several flavonoids with 
structural similarities to 2-SC have shown interesting results 
in this field (see [23, 24] for reviews). The present studies 
were performed with the human monocytic leukemia cell 
line (THP-1). These cells were chosen because they display 
many characteristics similar to human monocytes and have 
been used previously to study the inflammatory process [4, 
25-28]. 
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Fig. (1). Chemical structures of the tested 2-SC. 
2. MATERIAL AND METHODS 
2.1. Reagents 
THP-1 cells, RPMI 1640 medium, penicillin-
streptomycin, L-glutamine, fetal bovine serum (FBS), igepal, 
dithiothreitol, phenylmethanesulfonyl fluoride, aprotinin, 
leupeptin, pepsatin, and LPS from Escherichia Coli O26:B6 
were obtained from Sigma-Aldrich (St Louis, MO). All the 
reagents used were of analytical grade. 
2-Styrylchromones 1A-1D, 2A-2D and 3A-3D were syn-
thesised by the three step Baker-Venkataraman method, 
starting from the O-protected 2’-hydroxyacetophenones and 
cinnamoyl chlorides [29]. The first step involves the O-
acylation of the appropriate 2’-hydroxyacetophenones with 
cinnamoyl chloride derivatives to give 2’-cinnamoylo-
xyacetophenones. These intermediates were converted into 
5-aryl-3-hydroxy-1-(2-hydroxyaryl)-2,4-pentadien-1-ones by 
the base-catalysed Baker-Venkataraman rearrangement [30-
32]. The cyclodehydration of these -diketones with a mix-
ture of DMSO and a catalytic amount of iodine or p-
toluenesulfonic acid gives polybenzyloxy-2-SC, which were 
debenzylated by treatment with hydrogen bromide in acetic 
acid at reflux, to give the expected hydroxy-2-SC 1A-1D, 
2A-2D and 3A-3D, with NMR spectra identical to those in 
the cited literature. 
2.2. Equipment 
A microplate reader (Synergy HT, BIO-TEK), was used 
to perform the chemiluminescence and absorbance readings. 
2.3. Cell Culture 
THP-1 cells were maintained in RPMI 1640 medium 
supplemented with penicillin (100 U/mL), streptomycin (100 
g/mL), L-glutamine (2 mmol/L) and 10% FBS in a 5% CO2 
humid atmosphere at 37°C.  
2.4. NF-kB Activation  
THP-1 cells (1x106 cells/mL) were cultivated in 6-well 
plates and incubated with the test compounds or vehicle 
(DMSO) for 90 min and subsequently stimulated with LPS 
(0.1 g/mL) for 30 min. The nuclear extracts were then ob-
tained according to a previously described method [33] with 
minor modifications. Cells were collected on ice, centrifuged 
(870 x g) at 4ºC, for 5 min, and ressuspended in 1 mL of cell 
lysis buffer [10 mM Hepes (pH 7.9), 1.5 mM MgCl2, 10 mM 
KCl, 0.5 mM EDTA, 0.1 mM EGTA] supplemented with 
2% igepal, 1 mM dithiothreitol and 0.25 mM phen-
ylmethanesulfonyl fluoride. The samples were then incu-
bated on ice for 15 min and centrifuged (13,000 x g) at 4ºC, 
for 5 min. The supernatant was removed and the nuclear 
pellets were ressuspended in 100 L of nuclear lysis buffer 
solution [20 mM Hepes (pH 7.9), 420 mM NaCl, 1.5 mM 
MgCl2, 0.5 mM EDTA, and 20% glycerol] supplemented 
with 1 mM dithiothreitol, 0.25 mM phenylmethanesulfonyl, 
and 5 g/mL of each of the following protease inhibitors: 
aprotinin, leupeptin, and pepsatin. The mixture was kept on 
ice for 30 min, under intermittent agitation, and further cen-
trifuged (13,000 x g) at 4ºC, for 10 min. The supernatant was 
collected and stored at -80ºC. The protein content was meas-
ured using the DC Bio-Rad protein assay kit (Bio-Rad Labo-
ratories, Hercules, California, USA). 
The activated NF-kB contained in the nuclear extracts 
was measured by immunoassay, using a commercially avail-
able ELISA kit (Trans AM NF-kB p50 chemi) from Active 
Motif (Carlsbad, CA), according to the manufacturer’s in-
structions. Briefly, NF-kB was captured by binding to a con-
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sensus oligonucleotide (5-GGGACTTTCC-3) immobilized 
on a 96-well plate. The p50 subunit of NF-kB was deter-
mined by a chemiluminescent reaction using a specific pri-
mary antibody and a secondary horseradish peroxidase-
conjugated antibody. The results were expressed as the re-
duction of p50-dependent chemiluminescence signal rela-
tively to control (%). 
2.5. Cytokines/Chemokine Production 
THP-1 cells (1x106 cells/mL) were cultivated in 6-well 
plates and incubated with the test compounds or vehicle 
(DMSO) for 90 min and subsequently stimulated with LPS 
(0.1 g/mL) for 14 h. The cultures were then collected into 
microcentrifuge tubes and centrifuged (1,000 x g) for 10 
min. The supernatant was assayed for secreted cytokines 
(TNF-, IL-1, and IL-6), and chemokine (IL-8) using a 
commercially available ELISA Kit from SABiosciences 
(Frederick, MDbe), according to the manufacturer’s instruc-
tions. The detection was made by reading the absorbance at 
450 nm. The results were expressed as the reduction of cyto-
kines/chemokine-dependent absorption at 450 nm relatively 
to control (%). 
2.6. Cytotoxicity 
The effect of the 2-SC on the cell viability was assessed 
by the lactate dehydrogenase (LDH) leakage (as a measure 
of cell membrane integrity). The LDH activity was deter-
mined by following the rate of oxidation of NADH at 340 
nm [34]. 
2.7. Statistical Analysis 
The statistical analysis was performed by one-way analy-
sis of variance (ANOVA) followed by Dunnett’s multicom-
parison test using GraphPad Prism version 5.00 for Win-
dows, GraphPad Software, San Diego California, USA, 
http://www.graphpad.com. When comparing with control 
group, values of P less than 0.05 were considered significant. 
3. RESULTS 
3.1. NF-kB Activation 
Among the tested 2-SC from group 1, compound 1C was 
the most active, inhibiting the NF-kB activation in 65.7 ± 
11.5 % for the concentration of 50 M. From group 2, com-
pounds 2C and 2D appeared as the most actives, inhibiting 
the NF-kB activation in 30.2 ± 5.6 % and 26.5 ± 3.7 %, re-
spectively, for the concentration of 50 M. 2-SC from group 
3 revealed similar activities. Overall, compounds 1C, 2C and 
2D were the most potent and were able to significantly re-
duce the NF-kB activation induced by stimulation with LPS, 
compound 1C being the most effective of all. Therefore, this 
compound was tested at smaller concentrations exhibiting a 
concentration-dependent effect, which was still significant at 
25 M (Fig. 2). The other tested 2-SC rendered an inhibition 
of NF-kB activation lower than 20 %. 
3.2. Cytokines/Chemokine Production 
The three compounds that inhibited NF-kB activation, 
1C, 2C and 2D, were tested at the 50 M concentration for 
their ability to reduce proinflammatory cytokines/chemo-
kine production. All of them were capable of inhibit the pro-
duction of IL-6 almost totally. Moreover, compound 1C sig-
nificantly reduced the production of IL-1, TNF- and IL-8. 
As well compound 2D was able to significantly reduce the 
production of IL-1 and TNF-. The 2-styrylchromone 2C 
also inhibited the production of TNF- in 4.5 ± 2.0%. Still 
compounds 2C and 2D seem to induce the production of IL-
8. The 2-SC 2C also appear to induce IL-1 but in a lower 
extent (Fig. 3). 
3.3. Cytotoxicity 
None of the tested 2-SC, under the concentration of 50 
M, was cytotoxic to THP-1 cells after a 90 min incubation 
period, as verified by the LDH leakage assay. Compounds 
1C, 2C, and 2D were also further incubated for 16 h with the 
cells showing no cytotoxic effect (data not shown).  
 
Fig. (2). Inhibition of LPS-induced NF-kB activation in THP-1 cells by 2-SC (1A-1D, 2A-2D, 3A-3D). Each bar represents the percentage of 
reduction of p-50-dependent chemiluminescence signal relatively to control. The compounds were tested at the concentration of 50 M, ex-
cept where otherwise indicated. The control represents LPS-stimulated cells with DMSO. Each value represents mean±SEM of four experi-
ments. ***P<0.001, **P<0.01, *P<0.05, significantly different from control. 
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4. DISCUSSION 
Monocytes play an important role in initiating innate 
immune responses through the secretion of inflammatory 
mediators, namely cytokines [35]. 
In the present study we used the THP-1 cells because of 
their human origin and ability to perform many of the func-
tions of peripheral blood monocytes. Based on similar results 
of THP-1 and blood monocytes, the use of THP-1 cells al-
lows more reproducibility and the low variation makes them 
very useful for standardizing test and comparisons between 
compounds to be feasible [36]. In addition, THP-1 have been 
previously used to study the inflammatory process [4, 25-
28]. Inflammation is the process developed by the innate 
immunity in response to physical, physiological and/or oxi-
dative stress and is associated with activation of the NF-kB 
signaling pathway, which is conserved in all multicellular 
animals [1]. Furthermore, NF-kB is increasingly recognized 
as a crucial player in many steps of cancer initiation and pro-
gression [1]. The involvement of NF-kB proteins in the de-
velopment of common autoimmune and chronic inflamma-
tory diseases, including rheumatoid arthritis, multiple sclero-
sis, type 1 diabetes mellitus, thyroid autoimmune diseases, 
systemic lupus erythematosus as well as inflammatory bowel 
disease and psoriasis, has been demonstrated by in vitro and 
in vivo data [37]. 
Moreover, accepted therapeutic options such as glucocor-
ticoids, cyclosporine, tacrolimus, non-steroidal anti-
inflammatory drugs (NSAIDs), and sulfasalazine were 
shown to modulate the NF-kB pathway by several mecha-
nisms. In addition, novel therapeutic strategies that specifi-
cally inhibit key elements of this pathway are being devel-
oped, showing some interesting results in animal models of 
the above mentioned diseases, reviewed in [38]. Oxidative 
stress is defined as an imbalance between production of free 
radicals and reactive metabolites, so-called oxidants or reac-
tive oxygen species (ROS), and their elimination by protec-
tive mechanisms, referred to as antioxidants. This imbalance 
leads to damage of important biomolecules and cells, with 
potential impact on the whole organism [39]. Some of the 
studied compounds had previously shown high scavenging 
activity against ROS and reactive nitrogen species (RNS) 
[21]. Redox status has also been shown to have an impact on 
NF-kB regulation [39, 40]. The mechanism for activation of 
NF-kB by ROS is not clear, and the relationship between 
NF-kB and ROS is complex. Numerous polyphenols have 
been shown ascribe to inhibit NF-kB in different cell types. 
For example, quercetin suppresses NF-kB in J774 cells [41]. 
Apigenin blocks LPS stimulation of the NF-kB pathway in 
macrophages [42]. Catechin inhibits phorbol-12-myristate-
13-acetate (PMA)-induced NF-kB activation at multiple 
steps in Jurkat T cells [43]. Acacetin inhibits the NF-kB ac-
tivation in DU145 prostate cancer cells [44]. Luteolin pre-
vents LPS-induced TNF- expression in cardiac myocytes 
through the inhibition of the NF-kB signaling pathway [45]. 
Chrysin suppresses LPS-stimulated proinflammatory re-
sponses by blocking NF-kB in microglia cells [46]. Narin-
genin inhibits NF-kB activity in inflammatory pulmonary 
diseases induced by human neutrophil elastase [47]. How-
ever, the modulation of NF-kB activation by hydroxylated 2-
SC was reported here for the first time. 
The mechanisms of NF-kB activation are complex and 
depend on the activator and on the cell type. Herein we fo-
cused on the LPS-induced NF-kB activation in phagocytic 
cells, namely monocytes. LPS, the major outer membrane 
component present in gram-negative bacteria, consist of a 
lipid core and polysaccharide side chain joined by a covalent 
bond. LPS act as the prototypical endotoxin to promote the 
secretion of proinflammatory cytokines in many cell types. 
LPS is recognized by TLR4, a member of the TLR family. 
TLRs are evolutionarily conserved pattern recognition recep-
tors that recognize unique, essential molecules characteristic 
of various classes of microbes. The function of TLRs as arbi-
trators of self / nonself discrimination highlights their central 
role in innate immunity as well as in the initiation of the 
adaptive immune response [48, 49]. 
Upon binding of LPS to TLR4, the cytoplasmic region of 
the receptor recruits MyD88 (myeloid differentiation pri-
mary response gene 88), which links TLR4 to IL-1 receptor-
associated kinase (IRAK) and TNF receptor-associated fac-
tor-6 (TRAF6) that mediates NF-kB activation. On the other 
hand, the activation of Rac1 and the subsequent production 
of ROS are key steps involved in NF-kB activation and TNF 
 
Fig. (3). Inhibition of LPS-induced production of TNF-, IL-1, IL-6, and IL-8 in THP-1 cells by 2-SC (1C, 2C, and 2D). Each bar repre-
sents the percentage of reduction of the respective cytokine/chemokine-dependent absorption at 450 nm relatively to control. The compounds 
were tested at the concentration of 50 M. The control represents LPS-stimulated cells with DMSO. Each value represents mean±SEM of 
three experiments. ***P<0.001, **P<0.01, *P<0.05, significantly different from control. 
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secretion in macrophages activated with LPS. LPS-induced 
ROS generation and NF-kB activation was shown to be me-
diated by direct interaction of TLR4 with NADPH oxidase 4 
(Nox4), a protein related to the NADPH oxidase 2 (Nox2) 
present in phagocytic cells, although another Nox enzyme 
might be involved [40]. 
While the mechanism of NF-kB inhibition has been con-
sidered by some to be related to the antioxidant properties of 
the compounds [50, 51], the relevance of these properties to 
the activity of flavonoids was questioned by Comalada and 
coleagues [52] based on the observation that a good antioxi-
dant like kaempferol was a worse NF-kB inhibitor than api-
genin, which is a poor antioxidant. A similar situation oc-
curred with 2-SC, i.e., compounds like 1A and 1B, which 
previously showed high ROS scavenging activity [21], could 
not inhibit the LPS-induced NF-kB DNA-binding, while 
compounds 2C and 2D, which are much less active scaven-
gers, were effective in the present study. However, the lack 
of NF-kB inhibitory activity of good ROS scavengers such 
as 1A and 1B might be related to their poorer hydrophobic-
ity, compared with the active compounds 1C, 2C and 2D,
which can difficult their entry into cells. This rational comes 
in line with the results from a previous study [20], in which 
compounds 1A-1D were tested for their inhibitory effect on 
Cu2+-induced oxidation of isolated human serum low density 
lipoproteins (LDL), an in vitro model of lipid peroxidation. 
In that work, compounds 1C and 1D were much more effec-
tive than 1A and 1B. The unexpected differences observed in 
the antioxidant effectiveness were suggested to be due to the 
different partitioning of 2-SC into LDL as a function of the 
number of hydroxyl groups in the molecule. The authors 
studied the interaction of the SCs with the LDL by absorp-
tion and fluorescence spectroscopies and concluded that the 
less substituted ones interacted with the LDL in more than 
one site, enhancing their activity. Moreover, Brennan and 
Oneill [53] exposed the hypothesis that the reactive oxygen 
model of NF-kB activation depends on the type of cells un-
der study. In their study they reported different susceptibility 
of Jurkat, EL4 and KB cells to the antioxidant N-
acetylcystein, which also did not inhibit TNF-activated NF-
kB in KB cells. 
It is important to note that none of the tested 2-SC under 
the concentration of 50 M was cytotoxic to THP-1 cells as 
it was seen by LDH leakage assay. LDH is a cytosolic en-
zyme that is released when the plasma membrane is damaged 
[54]. 
The transcription factor NF-kB is responsible for the 
regulation of genes encoding proinflammatory cytokines 
[e.g., TNF-a, IL-1, IL-2, IL-6, IL-12, lymphotoxin (LT)a, 
LTb and granulocyte macrophage colony-stimulating factor 
(GM-CSF)], chemokines [e.g., IL-8, macrophage inflamma-
tory protein (MIP)-1a, monocyte chemoattractant protein 
(MCP)-1, regulated on activation, normal T Cell expressed 
and secreted (RANTES) and eotaxin], adhesion molecules 
[e.g., intercellular adhesion molecule (ICAM), vascular cell 
adhesion molecule (VCAM) and E-selectin], growth factors 
and inducible enzymes such as COX-2 and inducible nitric 
oxide synthase (iNOS) [55]. We focus our study in the effect 
of 2-SC in proinflammatory cytokines TNF-, IL-1, and IL-
6 and the chemokine IL-8 since they are known to be impli-
cated in chronic inflammatory and autoimmune diseases 
such as rheumatoid arthritis, multiple sclerosis, and inflam-
matory bowel disease [5-8]. Furthermore, the clinical effi-
cacy of drugs that target TNF-, IL-1, and IL-6 (e.g. mono-
clonal antibodies, receptor antagonists) has been well dem-
onstrated in rheumatoid arthritis and Crohn’s disease [5, 56-
58]. The results obtained in this work show that 1C is capa-
ble of reducing the production of TNF-, IL-1, IL-6, and 
IL-8, most likely by the previous inhibition of NF-kB activa-
tion. 2D, however, was unable to reduce IL-8 production. 
The same happened with 2C, which could not reduce IL-1
production as well. The fact that these two compounds were 
less potent inhibitors of NF-kB activation than 1C may be an 
explanation for the different results. 
In this study, new inhibitors of NF-kB activity were 
found. From all the tested compounds, 1C showed the high-
est activity in inhibiting this transcription factor and was also 
the best in reducing the production of all proinflammatory 
cytokines/chemokine tested. Thus, compound 1C is a prom-
ising scaffold for the development of new anti-inflammatory 
drugs. 
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